Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1957 1
1962 1
1963 1
1964 3
1965 1
1966 3
1967 5
1968 2
1969 4
1970 3
1971 2
1972 1
1973 6
1974 5
1975 6
1976 6
1977 6
1978 8
1979 5
1980 9
1981 9
1982 6
1983 4
1984 12
1985 15
1986 8
1987 15
1988 26
1989 8
1990 10
1991 18
1992 10
1993 19
1994 16
1995 15
1996 17
1997 13
1998 21
1999 21
2000 19
2001 27
2002 36
2003 32
2004 34
2005 37
2006 28
2007 32
2008 50
2009 50
2010 41
2011 38
2012 50
2013 63
2014 55
2015 53
2016 71
2017 79
2018 62
2019 66
2020 78
2021 90
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

1,310 results
Results by year
Filters applied: . Clear all
Page 1
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies.
Kumagai S, Togashi Y, Kamada T, Sugiyama E, Nishinakamura H, Takeuchi Y, Vitaly K, Itahashi K, Maeda Y, Matsui S, Shibahara T, Yamashita Y, Irie T, Tsuge A, Fukuoka S, Kawazoe A, Udagawa H, Kirita K, Aokage K, Ishii G, Kuwata T, Nakama K, Kawazu M, Ueno T, Yamazaki N, Goto K, Tsuboi M, Mano H, Doi T, Shitara K, Nishikawa H. Kumagai S, et al. Among authors: nishikawa h. Nat Immunol. 2020 Nov;21(11):1346-1358. doi: 10.1038/s41590-020-0769-3. Epub 2020 Aug 31. Nat Immunol. 2020. PMID: 32868929
Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603).
Fukuoka S, Hara H, Takahashi N, Kojima T, Kawazoe A, Asayama M, Yoshii T, Kotani D, Tamura H, Mikamoto Y, Hirano N, Wakabayashi M, Nomura S, Sato A, Kuwata T, Togashi Y, Nishikawa H, Shitara K. Fukuoka S, et al. Among authors: nishikawa h. J Clin Oncol. 2020 Jun 20;38(18):2053-2061. doi: 10.1200/JCO.19.03296. Epub 2020 Apr 28. J Clin Oncol. 2020. PMID: 32343640 Clinical Trial.
Roles of regulatory T cells in cancer immunity.
Takeuchi Y, Nishikawa H. Takeuchi Y, et al. Among authors: nishikawa h. Int Immunol. 2016 Aug;28(8):401-9. doi: 10.1093/intimm/dxw025. Epub 2016 May 9. Int Immunol. 2016. PMID: 27160722 Free PMC article. Review.
PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer.
Kamada T, Togashi Y, Tay C, Ha D, Sasaki A, Nakamura Y, Sato E, Fukuoka S, Tada Y, Tanaka A, Morikawa H, Kawazoe A, Kinoshita T, Shitara K, Sakaguchi S, Nishikawa H. Kamada T, et al. Among authors: nishikawa h. Proc Natl Acad Sci U S A. 2019 May 14;116(20):9999-10008. doi: 10.1073/pnas.1822001116. Epub 2019 Apr 26. Proc Natl Acad Sci U S A. 2019. PMID: 31028147 Free PMC article.
1,310 results